SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/F2CBA2DB2B1667E2C6B8EF725E9124B770B0E8665E56C2E44FF7EC551581C6E474365F52E53B4BD7C562BF317AA77254>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/F2CBA2DB2B1667E2C6B8EF725E9124B770B0E8665E56C2E44FF7EC551581C6E474365F52E53B4BD7C562BF317AA77254
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/F2CBA2DB2B1667E2C6B8EF725E9124B770B0E8665E56C2E44FF7EC551581C6E474365F52E53B4BD7C562BF317AA77254
http://www.w3.org/2000/01/rdf-schema#comment
"HLA-DPA1 overexpression inhibits cancer progression reduces resistance to cisplatin and correlates with increased immune infiltration in lung adenocarcinoma."
xsd:string
http://purl.uniprot.org/uniprot/#_B579B721984E232957361A078F6E4A4FDF55ECC6F6DDCE5675DDB4928117A1D9482C626D1FCE8A292C4D1D4F19DF05B5
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/F2CBA2DB2B1667E2C6B8EF725E9124B770B0E8665E56C2E44FF7EC551581C6E474365F52E53B4BD7C562BF317AA77254
http://purl.uniprot.org/uniprot/I2G9G1
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F2CBA2DB2B1667E2C6B8EF725E9124B770B0E8665E56C2E44FF7EC551581C6E474365F52E53B4BD7C562BF317AA77254
http://purl.uniprot.org/uniprot/#_I2G9G1-mappedCitation-37899135
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F2CBA2DB2B1667E2C6B8EF725E9124B770B0E8665E56C2E44FF7EC551581C6E474365F52E53B4BD7C562BF317AA77254